-
1
-
-
33645050923
-
Diabetes prevalence in England, 2001 - estimates from an epidemiological model
-
Forouhi NG, Merrick D, Goyder E, Ferguson BA, Abbas J, Lachowycz K, Wild SH: Diabetes prevalence in England, 2001 - estimates from an epidemiological model. Diabetic Med (2006) 23(2):189-197.
-
(2006)
Diabetic Med
, vol.23
, Issue.2
, pp. 189-197
-
-
Forouhi, N.G.1
Merrick, D.2
Goyder, E.3
Ferguson, B.A.4
Abbas, J.5
Lachowycz, K.6
Wild, S.H.7
-
2
-
-
2342466734
-
Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030
-
Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 27(5):1047-1053.
-
(2004)
Diabetes Care
, vol.27
, Issue.5
, pp. 1047-1053
-
-
Wild, S.1
Roglic, G.2
Green, A.3
Sicree, R.4
King, H.5
-
3
-
-
33845881411
-
-
Kahn SE, Hull RL, Utzschneider KM: Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature (2006) 444(7121):840-846. • Molecular mechanisms linking obesity to development of insulin resistance are described in this review with specific reference to β-cell failure.
-
Kahn SE, Hull RL, Utzschneider KM: Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature (2006) 444(7121):840-846. • Molecular mechanisms linking obesity to development of insulin resistance are described in this review with specific reference to β-cell failure.
-
-
-
-
4
-
-
0037219294
-
The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intraabdominal fat
-
Nieves DJ, Cnop M, Retzlaff B, Walden CE, Brunzell JD, Knopp RH, Kahn SE: The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intraabdominal fat. Diabetes (2003) 52(1):172-179.
-
(2003)
Diabetes
, vol.52
, Issue.1
, pp. 172-179
-
-
Nieves, D.J.1
Cnop, M.2
Retzlaff, B.3
Walden, C.E.4
Brunzell, J.D.5
Knopp, R.H.6
Kahn, S.E.7
-
5
-
-
11144355637
-
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity
-
Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM et al: Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem (2004) 279(13):12152-12162.
-
(2004)
J Biol Chem
, vol.279
, Issue.13
, pp. 12152-12162
-
-
Pajvani, U.B.1
Hawkins, M.2
Combs, T.P.3
Rajala, M.W.4
Doebber, T.5
Berger, J.P.6
Wagner, J.A.7
Wu, M.8
Knopps, A.9
Xiang, A.H.10
Utzschneider, K.M.11
-
6
-
-
34247577093
-
The DREAM Trial: Using ramipril and rosiglitazone to prevent diabetes
-
Shah V, Pratley RE: The DREAM Trial: Using ramipril and rosiglitazone to prevent diabetes. Curr Diab Rep (2007) 7(1):53-55.
-
(2007)
Curr Diab Rep
, vol.7
, Issue.1
, pp. 53-55
-
-
Shah, V.1
Pratley, R.E.2
-
8
-
-
0033525870
-
-
Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C et al: Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science (1999) 283(5407):1544-1548. •• This is an important pivotal study that demonstrated the role of PTP1B in insulin resistance and obesity using gene knockout technology. This knockout phenotype generated much interest in PTP1B as a drug target for type 2 diabetes.
-
Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C et al: Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science (1999) 283(5407):1544-1548. •• This is an important pivotal study that demonstrated the role of PTP1B in insulin resistance and obesity using gene knockout technology. This knockout phenotype generated much interest in PTP1B as a drug target for type 2 diabetes.
-
-
-
-
9
-
-
21244444303
-
-
Bialy L, Waldmann H: Inhibitors of protein tyrosine phosphatases: Next-generation drugs? Angew Chem Int Ed Engl (2005) 44(25):3814-3839. •• This review describes in detail various strategies that were applied in the development of small-molecule inhibitors of PTPs, by both academic research groups and biotechnology companies.
-
Bialy L, Waldmann H: Inhibitors of protein tyrosine phosphatases: Next-generation drugs? Angew Chem Int Ed Engl (2005) 44(25):3814-3839. •• This review describes in detail various strategies that were applied in the development of small-molecule inhibitors of PTPs, by both academic research groups and biotechnology companies.
-
-
-
-
10
-
-
0037221179
-
Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice
-
Gum RJ, Gaede LL, Koterski SL, Heindel M, Clampit JE, Zinker BA, Trevillyan JM, Ulrich RG, Jirousek MR, Rondinone CM: Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes (2003) 52(1):21-28.
-
(2003)
Diabetes
, vol.52
, Issue.1
, pp. 21-28
-
-
Gum, R.J.1
Gaede, L.L.2
Koterski, S.L.3
Heindel, M.4
Clampit, J.E.5
Zinker, B.A.6
Trevillyan, J.M.7
Ulrich, R.G.8
Jirousek, M.R.9
Rondinone, C.M.10
-
11
-
-
0029762957
-
Protein tyrosine phosphatase 1B interacts with the activated insulin receptor
-
Seely BL, Staubs PA, Reichart DR, Berhanu P, Milarski KL, Saltiel AR, Kusari J, Olefsky JM: Protein tyrosine phosphatase 1B interacts with the activated insulin receptor. Diabetes (1996) 45(10):1379-1385.
-
(1996)
Diabetes
, vol.45
, Issue.10
, pp. 1379-1385
-
-
Seely, B.L.1
Staubs, P.A.2
Reichart, D.R.3
Berhanu, P.4
Milarski, K.L.5
Saltiel, A.R.6
Kusari, J.7
Olefsky, J.M.8
-
12
-
-
0033942614
-
-
Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A et al: Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol (2000) 20(15):5479-5489. •• This is an important study that demonstrated the role of PTP1B in the regulation of metabolism. Mice lacking this enzyme are insulin sensitive and are resistant to diet-induced obesity.
-
Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe AH, Stricker-Krongrad A et al: Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol (2000) 20(15):5479-5489. •• This is an important study that demonstrated the role of PTP1B in the regulation of metabolism. Mice lacking this enzyme are insulin sensitive and are resistant to diet-induced obesity.
-
-
-
-
13
-
-
2642541849
-
Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action
-
Zabolotny JM, Haj FG, Kim YB, Kim HJ, Shulman GI, Kim JK, Neel BG, Kahn BB: Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem (2004) 279(23):24844-24851.
-
(2004)
J Biol Chem
, vol.279
, Issue.23
, pp. 24844-24851
-
-
Zabolotny, J.M.1
Haj, F.G.2
Kim, Y.B.3
Kim, H.J.4
Shulman, G.I.5
Kim, J.K.6
Neel, B.G.7
Kahn, B.B.8
-
14
-
-
33847060409
-
Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-α-induced insulin resistance
-
Nieto-Vazquez I, Fernández-Veledo S, de Alvaro C, Rondinone CM, Valverde AM, Lorenzo M: Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-α-induced insulin resistance. Diabetes (2007) 56(2):404-413.
-
(2007)
Diabetes
, vol.56
, Issue.2
, pp. 404-413
-
-
Nieto-Vazquez, I.1
Fernández-Veledo, S.2
de Alvaro, C.3
Rondinone, C.M.4
Valverde, A.M.5
Lorenzo, M.6
-
15
-
-
33845296085
-
Reversal of diet-induced insulin resistance with a single bout of exercise in the rat: The role of PTP1B and IRS-1 serine phosphorylation
-
Ropelle ER, Pauli JR, Prada PO, de Souza CT, Picardi PK, Faria MC, Cintra DE, Fernandes MF, Flores MB, Velloso LA, Saad MJ, Carvalheira JB: Reversal of diet-induced insulin resistance with a single bout of exercise in the rat: The role of PTP1B and IRS-1 serine phosphorylation. J Physiol (2006) 577(3):997-1007.
-
(2006)
J Physiol
, vol.577
, Issue.3
, pp. 997-1007
-
-
Ropelle, E.R.1
Pauli, J.R.2
Prada, P.O.3
de Souza, C.T.4
Picardi, P.K.5
Faria, M.C.6
Cintra, D.E.7
Fernandes, M.F.8
Flores, M.B.9
Velloso, L.A.10
Saad, M.J.11
Carvalheira, J.B.12
-
16
-
-
12444339055
-
PTP1B antisense-treated mice show regulation of genes involved in lipogenesis in liver and fat
-
Waring JF, Ciurlionis R, Clampit JE, Morgan S, Gum RJ, Jolly RA, Kroeger P, Frost L, Trevillyan J, Zinker BA, Jirousek M et al: PTP1B antisense-treated mice show regulation of genes involved in lipogenesis in liver and fat. Mol Cell Endocrinol (2003) 203(1-2):155-168.
-
(2003)
Mol Cell Endocrinol
, vol.203
, Issue.1-2
, pp. 155-168
-
-
Waring, J.F.1
Ciurlionis, R.2
Clampit, J.E.3
Morgan, S.4
Gum, R.J.5
Jolly, R.A.6
Kroeger, P.7
Frost, L.8
Trevillyan, J.9
Zinker, B.A.10
Jirousek, M.11
-
17
-
-
0037143754
-
-
Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF, Xie N, Wilcox D, Jacobson P, Frost L, Kroeger PE et al: PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci USA (2002) 99(17):11357-11362. • This report further validates PTP1B as a drug target. ISIS was the first pharmaceutical company that reported the development of PTP1B ASOs and its use in a mouse model of diabetes in vivo. ISIS-113715, a second generation ASO, is currently undergoing phase II clinical trials.
-
Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF, Xie N, Wilcox D, Jacobson P, Frost L, Kroeger PE et al: PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci USA (2002) 99(17):11357-11362. • This report further validates PTP1B as a drug target. ISIS was the first pharmaceutical company that reported the development of PTP1B ASOs and its use in a mouse model of diabetes in vivo. ISIS-113715, a second generation ASO, is currently undergoing phase II clinical trials.
-
-
-
-
18
-
-
0036329620
-
Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis
-
Rondinone CM, Trevillyan JM, Clampit J, Gum RJ, Berg C, Kroeger P, Frost L, Zinker BA, Reilly R, Ulrich R, Butler M et al: Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. Diabetes (2002) 51(8):2405-2411.
-
(2002)
Diabetes
, vol.51
, Issue.8
, pp. 2405-2411
-
-
Rondinone, C.M.1
Trevillyan, J.M.2
Clampit, J.3
Gum, R.J.4
Berg, C.5
Kroeger, P.6
Frost, L.7
Zinker, B.A.8
Reilly, R.9
Ulrich, R.10
Butler, M.11
-
19
-
-
33846548680
-
Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes
-
Gonzalez-Rodriguez A, Clampit JE, Escribano O, Benito M, Rondinone CM, Valverde AM: Developmental switch from prolonged insulin action to increased insulin sensitivity in protein tyrosine phosphatase 1B-deficient hepatocytes. Endocrinology (2007) 148(2):594-608.
-
(2007)
Endocrinology
, vol.148
, Issue.2
, pp. 594-608
-
-
Gonzalez-Rodriguez, A.1
Clampit, J.E.2
Escribano, O.3
Benito, M.4
Rondinone, C.M.5
Valverde, A.M.6
-
20
-
-
0347990604
-
Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice
-
Kushner JA, Haj FG, Klaman LD, Dow MA, Kahn BB, Neel BG, White MF: Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice. Diabetes (2004) 53(1):61-66.
-
(2004)
Diabetes
, vol.53
, Issue.1
, pp. 61-66
-
-
Kushner, J.A.1
Haj, F.G.2
Klaman, L.D.3
Dow, M.A.4
Kahn, B.B.5
Neel, B.G.6
White, M.F.7
-
21
-
-
0032567937
-
Disruption of IRS-2 causes type 2 diabetes in mice
-
Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF: Disruption of IRS-2 causes type 2 diabetes in mice. Nature (1998) 391(6670):900- 904.
-
(1998)
Nature
, vol.391
, Issue.6670
, pp. 900-904
-
-
Withers, D.J.1
Gutierrez, J.S.2
Towery, H.3
Burks, D.J.4
Ren, J.M.5
Previs, S.6
Zhang, Y.7
Bernal, D.8
Pons, S.9
Shulman, G.I.10
Bonner-Weir, S.11
White, M.F.12
-
22
-
-
14344255690
-
-
Winter CL, Lange JS, Davis MG, Gerwe GS, Downs TR, Peters KG, Kasibhatla B: A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats. Exp Biol Med (2005) 230(3):207-216. • This paper describes the use of a small-molecular weight compound that is an inhibitor of PTP1B in improving insulin sensitivity and preventing type 2 diabetes in Zucker diabetic fatty rats.
-
Winter CL, Lange JS, Davis MG, Gerwe GS, Downs TR, Peters KG, Kasibhatla B: A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats. Exp Biol Med (2005) 230(3):207-216. • This paper describes the use of a small-molecular weight compound that is an inhibitor of PTP1B in improving insulin sensitivity and preventing type 2 diabetes in Zucker diabetic fatty rats.
-
-
-
-
23
-
-
12344290477
-
Tyrosine phosphatases in vessel wall signaling
-
Kappert K, Peters KG, Böhmer FD, Ostman A: Tyrosine phosphatases in vessel wall signaling. Cardiovasc Res (2005) 65(3):587-598.
-
(2005)
Cardiovasc Res
, vol.65
, Issue.3
, pp. 587-598
-
-
Kappert, K.1
Peters, K.G.2
Böhmer, F.D.3
Ostman, A.4
-
24
-
-
33845391536
-
-
Vercauteren M, Remy E, Devaux C, Dautreaux B, Henry JP, Bauer F, Mulder P, van Huijsduijnen RH, Bombrun A, Thuillez C, Richard V: Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation (2006) 114(23):2498-2507. • Endothelial dysfunction is characterized by a decrease in nitric oxide (NO) production. PTP1B inhibition stimulates early eNOS phosphorylation and subsequent activation of NO synthase, thus, providing evidence that PTP1B plays a role in endothelial function. The results presented demonstrated for the first time that PTP1B inhibitors may be useful in the potential treatment of endothelial dysfunction.
-
Vercauteren M, Remy E, Devaux C, Dautreaux B, Henry JP, Bauer F, Mulder P, van Huijsduijnen RH, Bombrun A, Thuillez C, Richard V: Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure. Circulation (2006) 114(23):2498-2507. • Endothelial dysfunction is characterized by a decrease in nitric oxide (NO) production. PTP1B inhibition stimulates early eNOS phosphorylation and subsequent activation of NO synthase, thus, providing evidence that PTP1B plays a role in endothelial function. The results presented demonstrated for the first time that PTP1B inhibitors may be useful in the potential treatment of endothelial dysfunction.
-
-
-
-
25
-
-
0037205740
-
An attempt to promote neo-vascularization by employing a newly synthesized inhibitor of protein tyrosine phosphatase
-
Soeda S, Shimada T, Koyanagi S, Yokomatsu T, Murano T, Shibuya S, Shimeno H: An attempt to promote neo-vascularization by employing a newly synthesized inhibitor of protein tyrosine phosphatase. FEBS Lett (2002) 524(1-3):54-58.
-
(2002)
FEBS Lett
, vol.524
, Issue.1-3
, pp. 54-58
-
-
Soeda, S.1
Shimada, T.2
Koyanagi, S.3
Yokomatsu, T.4
Murano, T.5
Shibuya, S.6
Shimeno, H.7
-
26
-
-
3042579797
-
Tyrosine phosphatase inhibition augments collateral blood flow in a rat model of peripheral vascular disease
-
Carr AN, Davis MG, Eby-Wilkens E, Howard BW, Towne BA, Dufresne TE, Peters KG: Tyrosine phosphatase inhibition augments collateral blood flow in a rat model of peripheral vascular disease. Am J Physiol Heart Circ Physiol (2004) 287(1):H268-H276.
-
(2004)
Am J Physiol Heart Circ Physiol
, vol.287
, Issue.1
-
-
Carr, A.N.1
Davis, M.G.2
Eby-Wilkens, E.3
Howard, B.W.4
Towne, B.A.5
Dufresne, T.E.6
Peters, K.G.7
-
27
-
-
33644789964
-
Association of protein tyrosine phosphatase-N1 polymorphisms with coronary calcified plaque in the Diabetes Heart Study
-
Burdon KP, Bento JL, Langefeld CD, Campbell JK, Carr JJ, Wagenknecht LM, Herrington DM, Freedman BI, Rich SS, Bowden DW: Association of protein tyrosine phosphatase-N1 polymorphisms with coronary calcified plaque in the Diabetes Heart Study. Diabetes (2006) 55(3):651-658.
-
(2006)
Diabetes
, vol.55
, Issue.3
, pp. 651-658
-
-
Burdon, K.P.1
Bento, J.L.2
Langefeld, C.D.3
Campbell, J.K.4
Carr, J.J.5
Wagenknecht, L.M.6
Herrington, D.M.7
Freedman, B.I.8
Rich, S.S.9
Bowden, D.W.10
-
28
-
-
7044260741
-
Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes
-
Bento JL, Palmer ND, Mychaleckyj JC, Lange LA, Langefeld CD, Rich SS, Freedman BI, Bowden DW: Association of protein tyrosine phosphatase 1B gene polymorphisms with type 2 diabetes. Diabetes (2004) 53(11):3007-3012.
-
(2004)
Diabetes
, vol.53
, Issue.11
, pp. 3007-3012
-
-
Bento, J.L.1
Palmer, N.D.2
Mychaleckyj, J.C.3
Lange, L.A.4
Langefeld, C.D.5
Rich, S.S.6
Freedman, B.I.7
Bowden, D.W.8
-
29
-
-
33745975185
-
Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus
-
Freedman BI, Bowden DW, Sale MM, Langefeld CD, Rich SS: Genetic susceptibility contributes to renal and cardiovascular complications of type 2 diabetes mellitus. Hypertension (2006) 48(1):8-13.
-
(2006)
Hypertension
, vol.48
, Issue.1
, pp. 8-13
-
-
Freedman, B.I.1
Bowden, D.W.2
Sale, M.M.3
Langefeld, C.D.4
Rich, S.S.5
-
30
-
-
0032558725
-
Leptin and the regulation of body weight in mammals
-
Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature (1998) 395(6704):763-770.
-
(1998)
Nature
, vol.395
, Issue.6704
, pp. 763-770
-
-
Friedman, J.M.1
Halaas, J.L.2
-
31
-
-
4344644432
-
Body fat, leptin, and hypothalamic amenorrhea
-
Ahima RS: Body fat, leptin, and hypothalamic amenorrhea. N Engl J Med (2004) 351(10):959-962.
-
(2004)
N Engl J Med
, vol.351
, Issue.10
, pp. 959-962
-
-
Ahima, R.S.1
-
33
-
-
0033944070
-
Leptin regulation of neuroendocrine systems
-
Ahima RS, Saper CB, Flier JS, Elmquist JK: Leptin regulation of neuroendocrine systems. Front Neuroendocrinol (2000) 21(3):263-307.
-
(2000)
Front Neuroendocrinol
, vol.21
, Issue.3
, pp. 263-307
-
-
Ahima, R.S.1
Saper, C.B.2
Flier, J.S.3
Elmquist, J.K.4
-
35
-
-
0037297088
-
Leptin resistance - or why leptin fails to work in obesity
-
El-Haschimi K, Lehnert H: Leptin resistance - or why leptin fails to work in obesity. Exp Clin Endocrinol Diabetes (2003) 111(1):2-7.
-
(2003)
Exp Clin Endocrinol Diabetes
, vol.111
, Issue.1
, pp. 2-7
-
-
El-Haschimi, K.1
Lehnert, H.2
-
36
-
-
18344379861
-
-
Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG: PTP1B regulates leptin signal transduction in vivo. Dev Cell (2002) 2(4):489-495. •• This paper and reference [37 ••] describes the potential crosstalk between leptin and insulin signaling and Jak/STAT proteins via PTP1B.
-
Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG: PTP1B regulates leptin signal transduction in vivo. Dev Cell (2002) 2(4):489-495. •• This paper and reference [37 ••] describes the potential crosstalk between leptin and insulin signaling and Jak/STAT proteins via PTP1B.
-
-
-
-
37
-
-
0036228770
-
-
Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ, Kennedy BP, Tremblay ML: Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell (2002) 2(4):497-503. •• This paper and reference [36 ••] describes the potential crosstalk between leptin and insulin signaling and Jak/STAT proteins via PTP1B.
-
Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ, Kennedy BP, Tremblay ML: Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell (2002) 2(4):497-503. •• This paper and reference [36 ••] describes the potential crosstalk between leptin and insulin signaling and Jak/STAT proteins via PTP1B.
-
-
-
-
38
-
-
17844410359
-
Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling
-
Lund IK, Hansen JA, Andersen HS, Møller NP, Billestrup N: Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling. J Mol Endocrinol (2005) 34(2):339-351.
-
(2005)
J Mol Endocrinol
, vol.34
, Issue.2
, pp. 339-351
-
-
Lund, I.K.1
Hansen, J.A.2
Andersen, H.S.3
Møller, N.P.4
Billestrup, N.5
-
39
-
-
33746810001
-
-
Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG, Kahn BB: Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med (2006) 12(8):917-924. •• This paper describes tissue-specific PTP1B knockout mice and the phenotype. Neuronal knockout mice are characterized by reduced weight and adiposity, and energy expenditure in contrast to adipose muscle or liver tissue knockouts. These mice are hypersensitive to leptin, and show improved glucose homeostasis, demonstrating that PTP1B regulates body mass and adiposity primarily through its actions in the brain.
-
Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG, Kahn BB: Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med (2006) 12(8):917-924. •• This paper describes tissue-specific PTP1B knockout mice and the phenotype. Neuronal knockout mice are characterized by reduced weight and adiposity, and energy expenditure in contrast to adipose muscle or liver tissue knockouts. These mice are hypersensitive to leptin, and show improved glucose homeostasis, demonstrating that PTP1B regulates body mass and adiposity primarily through its actions in the brain.
-
-
-
-
40
-
-
0035816407
-
Insulin modulates leptin-induced STAT3 activation in rat hypothalamus
-
Carvalheira JB, Siloto RM, Ignacchitti I, Brenelli SL, Carvalho CR, Leite A, Velloso LA, Gontijo JA, Saad MJ: Insulin modulates leptin-induced STAT3 activation in rat hypothalamus. FEBS Lett (2001) 500(3):119- 124.
-
(2001)
FEBS Lett
, vol.500
, Issue.3
, pp. 119-124
-
-
Carvalheira, J.B.1
Siloto, R.M.2
Ignacchitti, I.3
Brenelli, S.L.4
Carvalho, C.R.5
Leite, A.6
Velloso, L.A.7
Gontijo, J.A.8
Saad, M.J.9
-
41
-
-
33845882537
-
Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age
-
Morrison CD, White CL, Wang Z, Lee SY, Lawrence DS, Cefalu WT, Zhang ZY, Gettys TW: Increased hypothalamic protein tyrosine phosphatase 1B contributes to leptin resistance with age. Endocrinology (2007) 148(1):433-440.
-
(2007)
Endocrinology
, vol.148
, Issue.1
, pp. 433-440
-
-
Morrison, C.D.1
White, C.L.2
Wang, Z.3
Lee, S.Y.4
Lawrence, D.S.5
Cefalu, W.T.6
Zhang, Z.Y.7
Gettys, T.W.8
-
42
-
-
33244479876
-
Leptin resistance following over-expression of protein tyrosine phosphatase 1B in liver
-
Lam NT, Covey SD, Lewis JT, Oosman S, Webber T, Hsu EC, Cheung AT, Kieffer TJ: Leptin resistance following over-expression of protein tyrosine phosphatase 1B in liver. J Mol Endocrinol (2006) 36(1):163- 174.
-
(2006)
J Mol Endocrinol
, vol.36
, Issue.1
, pp. 163-174
-
-
Lam, N.T.1
Covey, S.D.2
Lewis, J.T.3
Oosman, S.4
Webber, T.5
Hsu, E.C.6
Cheung, A.T.7
Kieffer, T.J.8
-
43
-
-
0347285350
-
A genomic perspective on protein tyrosine phosphatases: Gene structure, pseudogenes, and genetic disease linkage
-
Andersen JN, Jansen PG, Echwald SM, Mortensen OH, Fukada T, Del Vecchio R, Tonks NK, Møller NP: A genomic perspective on protein tyrosine phosphatases: Gene structure, pseudogenes, and genetic disease linkage. FASEB J (2004) 18(1):8-30.
-
(2004)
FASEB J
, vol.18
, Issue.1
, pp. 8-30
-
-
Andersen, J.N.1
Jansen, P.G.2
Echwald, S.M.3
Mortensen, O.H.4
Fukada, T.5
Del Vecchio, R.6
Tonks, N.K.7
Møller, N.P.8
-
44
-
-
0025276757
-
Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B
-
Brown-Shimer S, Johnson KA, Lawrence JB, Johnson C, Bruskin A, Green NR, Hill DE: Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B. Proc Natl Acad Sci USA (1990) 87(13):5148-5152.
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, Issue.13
, pp. 5148-5152
-
-
Brown-Shimer, S.1
Johnson, K.A.2
Lawrence, J.B.3
Johnson, C.4
Bruskin, A.5
Green, N.R.6
Hill, D.E.7
-
45
-
-
1842292786
-
Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q
-
Lembertas AV, Pérusse L, Chagnon YC, Fisler JS, Warden CH, Purcell-Huynh DA, Dionne FT, Gagnon J, Nadeau A, Lusis AJ, Bouchard C: Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest (1997) 100(5):1240-1247.
-
(1997)
J Clin Invest
, vol.100
, Issue.5
, pp. 1240-1247
-
-
Lembertas, A.V.1
Pérusse, L.2
Chagnon, Y.C.3
Fisler, J.S.4
Warden, C.H.5
Purcell-Huynh, D.A.6
Dionne, F.T.7
Gagnon, J.8
Nadeau, A.9
Lusis, A.J.10
Bouchard, C.11
-
46
-
-
24344444907
-
Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism
-
Ukkola O, Rankinen T, Lakka T, Leon AS, Skinner JS, Wilmore JH, Rao DC, Kesäniemi YA, Bouchard C: Protein tyrosine phosphatase 1B variant associated with fat distribution and insulin metabolism. Obes Res (2005) 13(5):829-834.
-
(2005)
Obes Res
, vol.13
, Issue.5
, pp. 829-834
-
-
Ukkola, O.1
Rankinen, T.2
Lakka, T.3
Leon, A.S.4
Skinner, J.S.5
Wilmore, J.H.6
Rao, D.C.7
Kesäniemi, Y.A.8
Bouchard, C.9
-
47
-
-
20044376516
-
Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people
-
Florez JC, Agapakis CM, Burtt NP, Sun M, Almgren P, Råstam L, Tuomi T, Gaudet D, Hudson TJ, Daly MJ, Ardlie KG et al: Association testing of the protein tyrosine phosphatase 1B gene (PTPN1) with type 2 diabetes in 7,883 people. Diabetes (2005) 54(6):1884-1891.
-
(2005)
Diabetes
, vol.54
, Issue.6
, pp. 1884-1891
-
-
Florez, J.C.1
Agapakis, C.M.2
Burtt, N.P.3
Sun, M.4
Almgren, P.5
Råstam, L.6
Tuomi, T.7
Gaudet, D.8
Hudson, T.J.9
Daly, M.J.10
Ardlie, K.G.11
-
48
-
-
0037205504
-
Structure determination of T cell protein-tyrosine phosphatase
-
Iversen LF, Moller KB, Pedersen AK, Peters GH, Petersen AS, Andersen HS, Branner S, Mortensen SB, Moller NP: Structure determination of T cell protein-tyrosine phosphatase. J Biol Chem (2002) 277(22): 19982-19990.
-
(2002)
J Biol Chem
, vol.277
, Issue.22
, pp. 19982-19990
-
-
Iversen, L.F.1
Moller, K.B.2
Pedersen, A.K.3
Peters, G.H.4
Petersen, A.S.5
Andersen, H.S.6
Branner, S.7
Mortensen, S.B.8
Moller, N.P.9
-
49
-
-
0034785827
-
Structural and evolutionary relationships among protein tyrosine phosphatase domains
-
Andersen JN, Mortensen OH, Peters GH, Drake PG, Iversen LF, Olsen OH, Jansen PG, Andersen HS, Tonks NK, Møller NP: Structural and evolutionary relationships among protein tyrosine phosphatase domains. Mol Cell Biol (2001) 21(21):7117-7136.
-
(2001)
Mol Cell Biol
, vol.21
, Issue.21
, pp. 7117-7136
-
-
Andersen, J.N.1
Mortensen, O.H.2
Peters, G.H.3
Drake, P.G.4
Iversen, L.F.5
Olsen, O.H.6
Jansen, P.G.7
Andersen, H.S.8
Tonks, N.K.9
Møller, N.P.10
-
50
-
-
11844295386
-
Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP
-
Galic S, Hauser C, Kahn BB, Haj FG, Neel BG, Tonks NK, Tiganis T: Coordinated regulation of insulin signaling by the protein tyrosine phosphatases PTP1B and TCPTP. Mol Cell Biol (2005) 25(2):819-829.
-
(2005)
Mol Cell Biol
, vol.25
, Issue.2
, pp. 819-829
-
-
Galic, S.1
Hauser, C.2
Kahn, B.B.3
Haj, F.G.4
Neel, B.G.5
Tonks, N.K.6
Tiganis, T.7
-
51
-
-
29144492209
-
Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: From diabetes, obesity to cell cycle, and cancer
-
Dubé N, Tremblay ML: Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: From diabetes, obesity to cell cycle, and cancer. Biochim Biophys Acta (2005) 1754(1-2):108-117.
-
(2005)
Biochim Biophys Acta
, vol.1754
, Issue.1-2
, pp. 108-117
-
-
Dubé, N.1
Tremblay, M.L.2
-
52
-
-
34248334251
-
TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-γ
-
Bourdeau A, Dubé N, Heinonen KM, Théberge JF, Doody KM, Tremblay ML: TC-PTP-deficient bone marrow stromal cells fail to support normal B lymphopoiesis due to abnormal secretion of interferon-γ. Blood (2007) 109(10):4220-4228.
-
(2007)
Blood
, vol.109
, Issue.10
, pp. 4220-4228
-
-
Bourdeau, A.1
Dubé, N.2
Heinonen, K.M.3
Théberge, J.F.4
Doody, K.M.5
Tremblay, M.L.6
-
53
-
-
15044343929
-
Cytoplasmic protein tyrosine phosphatases, regulation and function: The roles of PTP1B and TC-PTP
-
Bourdeau A, Dubé N, Tremblay ML: Cytoplasmic protein tyrosine phosphatases, regulation and function: The roles of PTP1B and TC-PTP. Curr Opin Cell Biol (2005) 17(2):203-209.
-
(2005)
Curr Opin Cell Biol
, vol.17
, Issue.2
, pp. 203-209
-
-
Bourdeau, A.1
Dubé, N.2
Tremblay, M.L.3
-
54
-
-
0030769147
-
Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice
-
You-Ten KE, Muise ES, Itié A, Michaliszyn E, Wagner J, Jothy S, Lapp WS, Tremblay ML: Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med (1997) 186(5):683-693.
-
(1997)
J Exp Med
, vol.186
, Issue.5
, pp. 683-693
-
-
You-Ten, K.E.1
Muise, E.S.2
Itié, A.3
Michaliszyn, E.4
Wagner, J.5
Jothy, S.6
Lapp, W.S.7
Tremblay, M.L.8
-
55
-
-
33847202286
-
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis
-
Julien SG, Dubé N, Read M, Penney J, Paquet M, Han Y, Kennedy BP, Muller WJ, Tremblay ML: Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nat Genet (2007) 39(3):338-346.
-
(2007)
Nat Genet
, vol.39
, Issue.3
, pp. 338-346
-
-
Julien, S.G.1
Dubé, N.2
Read, M.3
Penney, J.4
Paquet, M.5
Han, Y.6
Kennedy, B.P.7
Muller, W.J.8
Tremblay, M.L.9
-
56
-
-
4644350462
-
-
Dubé N, Tremblay ML: Beyond the metabolic function of PTP1B. Cell Cycle (2004) 3(5):550-553. • This review discusses the role of PTP1B beyond metabolic diseases. PTP1B plays a positive and negative role in the regulation of oncogenesis by modulating signaling via the Ras pathway, a key regulatory signaling molecule in cellular transformation.
-
Dubé N, Tremblay ML: Beyond the metabolic function of PTP1B. Cell Cycle (2004) 3(5):550-553. • This review discusses the role of PTP1B beyond metabolic diseases. PTP1B plays a positive and negative role in the regulation of oncogenesis by modulating signaling via the Ras pathway, a key regulatory signaling molecule in cellular transformation.
-
-
-
-
57
-
-
33847375227
-
Protein-tyrosine phosphatase 1B is required for HER2/neu-induced breast cancer
-
Bentires-Alj M, Neel BG: Protein-tyrosine phosphatase 1B is required for HER2/neu-induced breast cancer. Cancer Res (2007) 67(6):2420-2424.
-
(2007)
Cancer Res
, vol.67
, Issue.6
, pp. 2420-2424
-
-
Bentires-Alj, M.1
Neel, B.G.2
-
58
-
-
1242296879
-
The role of protein tyrosine phosphatase 1B in Ras signaling
-
Dubé N, Cheng A, Tremblay ML: The role of protein tyrosine phosphatase 1B in Ras signaling. Proc Natl Acad Sci USA (2004) 101(7):1834-1839.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, Issue.7
, pp. 1834-1839
-
-
Dubé, N.1
Cheng, A.2
Tremblay, M.L.3
-
59
-
-
33847391938
-
A brake becomes an accelerator: PTP1B - a new therapeutic target for breast cancer
-
Tonks NK, Muthuswamy SK: A brake becomes an accelerator: PTP1B - a new therapeutic target for breast cancer. Cancer Cell (2007) 11(3):214-216.
-
(2007)
Cancer Cell
, vol.11
, Issue.3
, pp. 214-216
-
-
Tonks, N.K.1
Muthuswamy, S.K.2
-
60
-
-
0028327324
-
Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: Association with p185c-erbB-2 protein expression
-
Wiener JR, Kerns BJ, Harvey EL, Conaway MR, Iglehart JD, Berchuck A, Bast RC Jr: Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: Association with p185c-erbB-2 protein expression. J Natl Cancer Inst (1994) 86(5):372-378.
-
(1994)
J Natl Cancer Inst
, vol.86
, Issue.5
, pp. 372-378
-
-
Wiener, J.R.1
Kerns, B.J.2
Harvey, E.L.3
Conaway, M.R.4
Iglehart, J.D.5
Berchuck, A.6
Bast Jr, R.C.7
-
61
-
-
0034731372
-
Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines
-
Bjorge JD, Pang A, Fujita DJ: Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines. J Biol Chem (2000) 275(52):41439-41446.
-
(2000)
J Biol Chem
, vol.275
, Issue.52
, pp. 41439-41446
-
-
Bjorge, J.D.1
Pang, A.2
Fujita, D.J.3
-
62
-
-
22144493870
-
EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases
-
DeYulia GJ Jr, Cárcamo JM: EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases. Biochem Biophys Res Commun (2005) 334(1):38-42.
-
(2005)
Biochem Biophys Res Commun
, vol.334
, Issue.1
, pp. 38-42
-
-
DeYulia Jr, G.J.1
Cárcamo, J.M.2
-
63
-
-
0042734919
-
Reactive oxygen species as mediators of cell adhesion
-
Chiarugi P: Reactive oxygen species as mediators of cell adhesion. Ital J Biochem (2003) 52(1):28-32.
-
(2003)
Ital J Biochem
, vol.52
, Issue.1
, pp. 28-32
-
-
Chiarugi, P.1
-
64
-
-
5444269960
-
Organization of functional domains in the docking protein p130Cas
-
Nasertorabi F, Garcia-Guzman M, Briknarová K, Larsen E, Havert ML, Vuori K, Ely KR: Organization of functional domains in the docking protein p130Cas. Biochem Biophys Res Commun (2004) 324(3):993-998.
-
(2004)
Biochem Biophys Res Commun
, vol.324
, Issue.3
, pp. 993-998
-
-
Nasertorabi, F.1
Garcia-Guzman, M.2
Briknarová, K.3
Larsen, E.4
Havert, M.L.5
Vuori, K.6
Ely, K.R.7
-
65
-
-
33947174540
-
-
Isis Pharmaceuticals Inc: Isis Pharmaceuticals and Symphony GenIsis enter into $75 million product development collaboration, April 07
-
Isis Pharmaceuticals Inc: Isis Pharmaceuticals and Symphony GenIsis enter into $75 million product development collaboration. Press Release (2006): April 07.
-
(2006)
Press Release
-
-
-
66
-
-
34848922479
-
ISIS 113715 improves glucose control in patients with type 2 diabetes
-
Isis Pharmaceuticals Inc: Isis Pharmaceuticals reports positive phase 2 data:, June 13
-
Isis Pharmaceuticals Inc: Isis Pharmaceuticals reports positive phase 2 data: ISIS 113715 improves glucose control in patients with type 2 diabetes. Press Release (2006): June 13.
-
(2006)
Press Release
-
-
-
67
-
-
34848921222
-
Early preclinical research shows ability to silence PTP-1B expression
-
Sirna Therapeutics Inc: Sirna Therapeutics launches program to treat diabetes with RNAi technology:, January 06
-
Sirna Therapeutics Inc: Sirna Therapeutics launches program to treat diabetes with RNAi technology: Early preclinical research shows ability to silence PTP-1B expression. Press Release (2005): January 06.
-
(2005)
Press Release
-
-
-
68
-
-
20444381342
-
-
VioQuest Pharmaceuticals Inc: Tropical disease leads to treatment for cancer, August 18
-
VioQuest Pharmaceuticals Inc: Tropical disease leads to treatment for cancer. Press Release (2005): August 18.
-
(2005)
Press Release
-
-
-
69
-
-
34848820960
-
-
New drugs in the R&D pipeline. Pharma Jpn (2006) 2021:9.
-
New drugs in the R&D pipeline. Pharma Jpn (2006) 2021:9.
-
-
-
-
70
-
-
0028077830
-
Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp
-
Burke TR Jr, Kole HK, Roller PP: Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp. Biochem Biophys Res Commun (1994) 204(1):129-134.
-
(1994)
Biochem Biophys Res Commun
, vol.204
, Issue.1
, pp. 129-134
-
-
Burke Jr, T.R.1
Kole, H.K.2
Roller, P.P.3
-
71
-
-
0028785789
-
Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases?
-
Chen L, Wu L, Otaka A, Smyth MS, Roller PP, Burke TR Jr, den Hertog J, Zhang ZY: Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases? Biochem Biophys Res Commun (1995) 216(3):976- 984.
-
(1995)
Biochem Biophys Res Commun
, vol.216
, Issue.3
, pp. 976-984
-
-
Chen, L.1
Wu, L.2
Otaka, A.3
Smyth, M.S.4
Roller, P.P.5
Burke Jr, T.R.6
den Hertog, J.7
Zhang, Z.Y.8
-
72
-
-
10744228866
-
The development of potent non-peptidic PTP-1B inhibitors
-
Dufresne C, Roy P, Wang Z, Asante-Appiah E, Cromlish W, Boie Y, Forghani F, Desmarais S, Wang Q, Skorey K, Waddleton D et al: The development of potent non-peptidic PTP-1B inhibitors. Bioorg Med Chem Lett (2004) 14(4):1039-1042.
-
(2004)
Bioorg Med Chem Lett
, vol.14
, Issue.4
, pp. 1039-1042
-
-
Dufresne, C.1
Roy, P.2
Wang, Z.3
Asante-Appiah, E.4
Cromlish, W.5
Boie, Y.6
Forghani, F.7
Desmarais, S.8
Wang, Q.9
Skorey, K.10
Waddleton, D.11
-
73
-
-
32044449378
-
-
Klopfenstein SR, Evdokimov AG, Colson AO, Fairweather NT, Neuman JJ, Maier MB, Gray JL, Gerwe GS, Stake GE, Howard BW, Farmer JA et al: 1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors. Bioorg Med Chem Lett (2006) 16(6):1574-1578.
-
Klopfenstein SR, Evdokimov AG, Colson AO, Fairweather NT, Neuman JJ, Maier MB, Gray JL, Gerwe GS, Stake GE, Howard BW, Farmer JA et al: 1,2,3,4-Tetrahydroisoquinolinyl sulfamic acids as phosphatase PTP1B inhibitors. Bioorg Med Chem Lett (2006) 16(6):1574-1578.
-
-
-
-
74
-
-
0031457541
-
Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: A paradigm for inhibitor design
-
Puius YA, Zhao Y, Sullivan M, Lawrence DS, Almo SC, Zhang ZY: Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: A paradigm for inhibitor design. Proc Natl Acad Sci USA (1997) 94(25):13420-13425.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, Issue.25
, pp. 13420-13425
-
-
Puius, Y.A.1
Zhao, Y.2
Sullivan, M.3
Lawrence, D.S.4
Almo, S.C.5
Zhang, Z.Y.6
-
75
-
-
0035861668
-
-
Shen K, Keng YF, Wu L, Guo XL, Lawrence DS, Zhang ZY: Acquisition of a specific and potent PTP1B inhibitor from a novel combinatorial library and screening procedure. J Biol Chem (2001) 276(50):47311-47319. •This paper describes the identification of potent and novel PTP1B inhibitors using a combinatorial chemistry approach to rapidly delineate scaffolds for further permeability optimization.
-
Shen K, Keng YF, Wu L, Guo XL, Lawrence DS, Zhang ZY: Acquisition of a specific and potent PTP1B inhibitor from a novel combinatorial library and screening procedure. J Biol Chem (2001) 276(50):47311-47319. •This paper describes the identification of potent and novel PTP1B inhibitors using a combinatorial chemistry approach to rapidly delineate scaffolds for further permeability optimization.
-
-
-
-
76
-
-
0242417581
-
Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy
-
Szczepankiewicz BG, Liu G, Hajduk PJ, Abad-Zapatero C, Pei Z, Xin Z, Lubben TH, Trevillyan JM, Stashko MA, Ballaron SJ, Liang H et al: Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy. J Am Chem Soc (2003) 125(14):4087-4096.
-
(2003)
J Am Chem Soc
, vol.125
, Issue.14
, pp. 4087-4096
-
-
Szczepankiewicz, B.G.1
Liu, G.2
Hajduk, P.J.3
Abad-Zapatero, C.4
Pei, Z.5
Xin, Z.6
Lubben, T.H.7
Trevillyan, J.M.8
Stashko, M.A.9
Ballaron, S.J.10
Liang, H.11
-
77
-
-
33846916227
-
Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives
-
Stuible M, Zhao L, Aubry I, Schmidt-Arras D, Böhmer FD, Li CJ, Tremblay ML: Cellular inhibition of protein tyrosine phosphatase 1B by uncharged thioxothiazolidinone derivatives. Chembiochem (2007) 8(2):179-186.
-
(2007)
Chembiochem
, vol.8
, Issue.2
, pp. 179-186
-
-
Stuible, M.1
Zhao, L.2
Aubry, I.3
Schmidt-Arras, D.4
Böhmer, F.D.5
Li, C.J.6
Tremblay, M.L.7
-
78
-
-
3543017313
-
-
Wiesmann C, Barr KJ, Kung J, Zhu J, Erlanson DA, Shen W, Fahr BJ, Zhong M, Taylor L, Randal M, McDowell RS, Hansen SK: Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol (2004) 11(8):730-737. •• This paper discloses the inhibitory activity, binding pocket and co-crystalization of benzofuran molecules in a non-catalytic binding site of PTP1B, thus providing evidence for the potential use of more cell permeable scaffolds for inhibition of the phosphatase.
-
Wiesmann C, Barr KJ, Kung J, Zhu J, Erlanson DA, Shen W, Fahr BJ, Zhong M, Taylor L, Randal M, McDowell RS, Hansen SK: Allosteric inhibition of protein tyrosine phosphatase 1B. Nat Struct Mol Biol (2004) 11(8):730-737. •• This paper discloses the inhibitory activity, binding pocket and co-crystalization of benzofuran molecules in a non-catalytic binding site of PTP1B, thus providing evidence for the potential use of more cell permeable scaffolds for inhibition of the phosphatase.
-
-
-
-
79
-
-
19644378636
-
Allosteric inhibition of PTP1B activity by selective modification of a non-active site cysteine residue
-
Hansen SK, Cancilla MT, Shiau TP, Kung J, Chen T, Erlanson DA: Allosteric inhibition of PTP1B activity by selective modification of a non-active site cysteine residue. Biochemistry (2005) 44(21):7704-7712.
-
(2005)
Biochemistry
, vol.44
, Issue.21
, pp. 7704-7712
-
-
Hansen, S.K.1
Cancilla, M.T.2
Shiau, T.P.3
Kung, J.4
Chen, T.5
Erlanson, D.A.6
-
80
-
-
33646196499
-
Residues distant from the active site influence protein-tyrosine phosphatase 1B inhibitor binding
-
Montalibet J, Skorey K, McKay D, Scapin G, Asante-Appiah E, Kennedy BP: Residues distant from the active site influence protein-tyrosine phosphatase 1B inhibitor binding. J Biol Chem (2006) 281(8):5258-5266.
-
(2006)
J Biol Chem
, vol.281
, Issue.8
, pp. 5258-5266
-
-
Montalibet, J.1
Skorey, K.2
McKay, D.3
Scapin, G.4
Asante-Appiah, E.5
Kennedy, B.P.6
-
81
-
-
33646828668
-
A targeted molecular dynamics study of WPD loop movement in PTP1B
-
Kamerlin SC, Rucker R, Boresch S: A targeted molecular dynamics study of WPD loop movement in PTP1B. Biochem Biophys Res Commun (2006) 345(3):1161-1166.
-
(2006)
Biochem Biophys Res Commun
, vol.345
, Issue.3
, pp. 1161-1166
-
-
Kamerlin, S.C.1
Rucker, R.2
Boresch, S.3
-
82
-
-
33847383241
-
Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug
-
Boutselis IG, Yu X, Zhang ZY, Borch RF: Synthesis and cell-based activity of a potent and selective protein tyrosine phosphatase 1B inhibitor prodrug. J Med Chem (2007) 50(4):856-864.
-
(2007)
J Med Chem
, vol.50
, Issue.4
, pp. 856-864
-
-
Boutselis, I.G.1
Yu, X.2
Zhang, Z.Y.3
Borch, R.F.4
-
83
-
-
33744786265
-
Design and synthesis of phosphotyrosine peptidomimetic prodrugs
-
Garrido-Hernandez H, Moon KD, Geahlen RL, Borch RF: Design and synthesis of phosphotyrosine peptidomimetic prodrugs. J Med Chem (2006) 49(11):3368-3376.
-
(2006)
J Med Chem
, vol.49
, Issue.11
, pp. 3368-3376
-
-
Garrido-Hernandez, H.1
Moon, K.D.2
Geahlen, R.L.3
Borch, R.F.4
-
85
-
-
34848830179
-
-
JAPAN TOBACCO INC (Inaba T, Ikemoto T, Sakata S, Maegawa H, Kashiwagi A): Azole compounds and medicinal use thereof. WO-03048140 (2003).
-
JAPAN TOBACCO INC (Inaba T, Ikemoto T, Sakata S, Maegawa H, Kashiwagi A): Azole compounds and medicinal use thereof. WO-03048140 (2003).
-
-
-
|